Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory […]
• First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single […]
….to help in identifying patients at high risk of severe inflammatory response • FDA EUA1 now makes IL-6 testing accessible to patients in the United […]
The European Commission yesterday published a roadmap for the evaluation of the EU legislation on the sustainable use of pesticides and an inception impact assessment […]
• Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future • Roche is […]
The current COVID-19 pandemic has a considerable impact on citizens, patients and businesses. It may force marketing authorisation holders of medicinal products and regulatory authorities […]
On April 9, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Terumo BCT Inc. and Marker Therapeutics AG […]
On April 9, 2020, the U.S. Food and Drug Administration granted an emergency use authorization to STERIS Corporation for the STERIS V-PRO 1 Plus, maX […]
Copyright © 2021 | WordPress Theme by MH Themes